We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Hospital Universitari de Bellvitge.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01268956
First Posted: January 4, 2011
Last Update Posted: January 4, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hospital Universitari de Bellvitge
  Purpose
Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis

Condition
Ovarian Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Correlation of Circulating Lymphatic Progenitor Cells With Lymph Node Metastasis in Ovarian Cancer Patients

Resource links provided by NLM:


Further study details as provided by Hospital Universitari de Bellvitge:

Biospecimen Retention:   Samples Without DNA
blood serum

Estimated Enrollment: 60
Study Start Date: January 2011
Estimated Study Completion Date: September 2011
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Lymphatic progenitor cell
Circulating lymphatic progenitor cell
Control
healthy people

Detailed Description:
Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis in ovarian cancer patients
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
ovarian cancer patients
Criteria

Inclusion Criteria:

  • ovarian cancer patients diagnosed by pathologic examination

Exclusion Criteria:

  • other malignant disease inflammatory disease untreated diabetic and hypertension chronic renal failure rheumatoid arthritis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01268956


Contacts
Contact: Huiling Qiu Zhiqing Liang, Doctor 86-23-68754813 zhi.lzliang@gmail.com

Locations
China, Sichuan
Department of Obstetrics & Gynecology, Southwest Hospital Enrolling by invitation
Chongqing, Sichuan, China, 400038
Sponsors and Collaborators
Hospital Universitari de Bellvitge
Investigators
Principal Investigator: Pianyifan pianyifan, Doctor Southwest Hospital, China
  More Information

Responsible Party: Huiling Qiu, Department of Obstetrics & Gynecology, Southwest Hospital
ClinicalTrials.gov Identifier: NCT01268956     History of Changes
Other Study ID Numbers: 20101231001
First Submitted: January 3, 2011
First Posted: January 4, 2011
Last Update Posted: January 4, 2011
Last Verified: December 2010

Additional relevant MeSH terms:
Ovarian Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders


To Top